This inventor holds 1 USPTO granted patent. Top assignee: Chemedica S.a.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Innovations in Ophthalmic Formulations by Rene-Pierre Buenter
Introduction
Rene-Pierre Buenter is a notable inventor based in Venthone, Switzerland. He has made significant contributions to the field of ophthalmology, particularly through his innovative formulations designed for eye surgery. His work focuses on enhancing surgical outcomes and patient comfort.
Latest Patents
Rene-Pierre Buenter holds a patent for a sodium hyaluronate-based ophthalmic formulation intended for use in eye surgery. This formulation comprises sodium hyaluronate, citrate, at least one antioxidant tolerated by intraocular tissues, and a phosphate buffer. This invention aims to improve the safety and effectiveness of eye surgeries.
Career Highlights
Buenter is associated with Chemedica S.A., a company known for its advancements in medical and pharmaceutical products. His role at Chemedica has allowed him to contribute to the development of innovative solutions in ophthalmology.
Conclusion
Rene-Pierre Buenter's work exemplifies the importance of innovation in medical science, particularly in enhancing surgical techniques and patient care in ophthalmology. His contributions continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile